A Phase I, Subject and Investigator Blind Randomized, Study to Investigate the Pharmacokinetics, Safety and Tolerability of Retosiban in Healthy Japanese Women
Phase of Trial: Phase I
Latest Information Update: 15 May 2017
At a glance
- Drugs Retosiban (Primary)
- Indications Preterm labour
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 07 Jun 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 06 Mar 2015 New trial record